Report
Where Pharma-Grade Nutraceuticals Go Next
This comprehensive report examines how leading developers are building defensible, clinically credible products in an increasingly complex regulatory environment.
Whether you're exploring FDA guidelines, EU health claim regulations, or multi-market compliance challenges, this resource provides the strategic framework and operational insights needed to navigate the beauty-pharma intersection.

Who should read the report
Decision-makers in pharma-grade/medical nutrition segment (pharma/clinical), business development leaders, sourcing and procurement managers, brand owners, product managers, R&D and formulation teams, QA and regulatory professionals.
Key insights you'll gain
- Evidence-Driven Differentiation
Discover how product-specific clinical substantiation transforms from regulatory requirement into commercial asset, enabling premium positioning across pharmacy, dermatology, and medical aesthetics channels.
- Supply Chain as Strategic Advantage
Learn how pharmaceutical-grade traceability systems—chain-of-custody documentation, supplier qualification, and ingredient authentication—simultaneously mitigate adulteration risk, support responsible-sourcing claims, and build consumer trust.
Download the report
New zone 2027: Nutraceuticals
Nutraceuticals with a pharmaceutical address
A new zone at CPHI Frankfurt 2027 for pharma-grade supplement makers, contract manufacturers and formulators selling into pharmacy and clinical channels - not retail.
Frankfurt, Germany, 9-11 November 2027
New zone
Nutraceuticals
Accelerated by the wave in metabolic health products, pharma is more closely aligned with nutrition than ever before. The new Nutraceuticals Zone at CPHI Frankfurt 2027 is built for that demand: finished nutraceutical products, contract manufacturing and formulation, developed to pharmaceutical standards and sold through pharmacy and clinical channels. This is the pharma-channel market, putting you in front of the CDMO, R&D and brand buyers already sourcing here.
A $347B market growing at nearly 10% a year
Metabolic health and weight-management fueling demand for more advanced nutraceutical solutions
Buyers are sourcing clinically-backed ingredients for gut health, immunity, and cognition
CPHI in numbers
Europe's largest pharmaceutical event
Nutraceuticals zone
Who you could join
Brand owners & product managers
running portfolio expansion into medical and pharma-grade nutrition.
Business development & sourcing leaders
evaluating contract-manufacturing and private-label partners.
R&D & formulation teams
working on bioavailability, delivery and new actives.
Commercial & growth leaders
opening new categories alongside drug therapy.
Regulatory & quality professionals
clearing products for the EU and beyond.
Exhibit
Secure your founding exhibitor position in the Nutraceuticals zone at CPHI Frankfurt 2027 and help define the future of evidence-led nutrition within pharma.
Attend
Curious to experience the event first-hand?
Meet us at CPHI Milan 2026, where we're building a dedicated agenda for eligible new exhibitors in this space, before you join the founding cohort of the Nutraceutical zone at CPHI Frankfurt 2027.
